HAVCR2 (Q8TDQ0) variants and mutations
HAVCR2 (also known as Q8TDQ0) is a human protein-coding gene encoding a hepatitis A virus cellular receptor 2 protein. It modulates activation and exhaustion of T cells and other immune cells in response to ligands in inflamed tissues. Biallelic loss-of-function variants can cause severe immune dysregulation with subcutaneous panniculitis-like T-cell lymphoma and hemophagocytic lymphohistiocytosis. This analysis covers 596 HAVCR2 variants and mutations. Of these, 80% have computational variant effect predictions. Disease context includes subcutaneous panniculitis-like T-cell lymphoma, neoplasm, and myelodysplastic syndrome. Example HAVCR2 variants include S3L, H4R, and L5F.
Variant analysis overview
- Gene: HAVCR2
- Protein: Q8TDQ0
- UniProt accession: Q8TDQ0
- Organism: Homo sapiens
- Variants analyzed: 596
- Variant scope: all variants
- Completed: 2026-08-21
Variant and mutation evidence
- Variant composition: 383 unspecified-consequence records; 75 synonymous variants; 103 missense variants; 4 in-frame deletions; 7 stop-gained variants; 22 frameshift variants; 1 in-frame insertions; 1 splice-region variants
- Prediction scores: 476 variants have prediction scores (80% of the analyzed set).
Clinical, disease, and population context
- Disease context: 25 disease associations are represented. Top associations: subcutaneous panniculitis-like T-cell lymphoma, neoplasm, myelodysplastic syndrome, non-small cell lung carcinoma, late-onset Alzheimers disease, chronic myelomonocytic leukemia, dementia, HAVCR2-related cancer predisposition, acute myeloid leukemia, hepatocellular carcinoma, melanoma, cervical cancer.
Protein structure and variant hotspots
- Protein features: 1 transmembrane segments; 1 domains; 4 binding sites; 3 post-translational modification sites.
- Structural context: 209 variants have structural context.
- PTM context: 9 variants overlap post-translational modification sites.
Data sources
Evidence in this analysis draws on EBI Proteins Variation, UniProt, gnomAD v4, EuropePMC, Interaction Network Analysis, Protein Data Bank, AlphaFold DB, gnomAD constraint, Open Targets, MaveDB, LitVar.
Notable HAVCR2 variants
Examples include S3L, H4R, L5F, P6R, P6S, D8G, C9G, C9R. Listed records include available protein-change notation, database identifiers, clinical classifications, computational predictions, population evidence, experimental measurements, and disease context.
- S3L (p.Ser3Leu), cosmic curated COSV57153, Ensembl rs973308543
- H4R (p.His4Arg), ExAC rs767716690, gnomAD rs767716690, REVEL 0.12, CADD 8.12
- L5F (p.Leu5Phe), rs1372149834, gnomAD rs1372149834, AlphaMissense 0.08, MetaLR 0.04, Variant assessed as somatic; moderate impact.
- P6R (p.Pro6Arg), TOPMed rs1757290580
- P6S (p.Pro6Ser), NCI-TCGA Cosmic COSV5715, cosmic curated COSV57152, Variant assessed as somatic; moderate impact.
- D8G (p.Asp8Gly), gnomAD rs1757290544, REVEL 0.10, CADD 21.10
- C9G (p.Cys9Gly), Ensembl rs1007359436
- C9R (p.Cys9Arg), Ensembl rs1007359436
- C9S (p.Cys9Ser), ESP rs142180056, ExAC rs142180056, TOPMed rs142180056, gnomAD rs142180056, REVEL 0.07, CADD 22.80
- C9W (p.Cys9Trp), ExAC rs771412436, gnomAD rs771412436, REVEL 0.11, CADD 23.50
- C9Y (p.Cys9Tyr), ESP rs142180056, ExAC rs142180056, TOPMed rs142180056, gnomAD rs142180056
- L13Q (p.Leu13Gln), ExAC rs749841722, TOPMed rs749841722, gnomAD rs749841722, REVEL 0.21, CADD 24.50
- L14P (p.Leu14Pro), NCI-TCGA Cosmic COSV5715, cosmic curated COSV57153, Variant assessed as somatic; moderate impact.
- L17P (p.Leu17Pro), ExAC rs769374342, gnomAD rs769374342, REVEL 0.12, CADD 22.70
- L18F (p.Leu18Phe), NCI-TCGA Cosmic COSV1003, cosmic curated COSV10032, Variant assessed as somatic; moderate impact.
- T19K (p.Thr19Lys), gnomAD rs1452632546, REVEL 0.14, CADD 24.60
- R20=, NCI-TCGA Cosmic COSV5715, Variant assessed as somatic; low impact.
- R20S (p.Arg20Ser), ExAC rs779965942, gnomAD rs779965942, REVEL 0.05, CADD 7.03
- R20T (p.Arg20Thr), ExAC rs746710199, TOPMed rs746710199, gnomAD rs746710199, REVEL 0.11, CADD 22.20
- S21F (p.Ser21Phe), NCI-TCGA Cosmic COSV1003, cosmic curated COSV10032, REVEL 0.08, CADD 22.90, Variant assessed as somatic; moderate impact.
- S22* (p.Ser22Ter), NCI-TCGA Cosmic COSV1003, cosmic curated COSV10032, Variant assessed as somatic; high impact.
- S22L (p.Ser22Leu), NCI-TCGA Cosmic COSV1003, REVEL 0.03, CADD 5.00, Variant assessed as somatic; moderate impact.
- S22P (p.Ser22Pro), TOPMed rs1220937456
- S22T (p.Ser22Thr), TOPMed rs1220937456
- V24A (p.Val24Ala), TOPMed rs1036687230, gnomAD rs1036687230, REVEL 0.01, CADD 0.34
- V24E (p.Val24Glu), TOPMed rs1036687230, gnomAD rs1036687230
- V24M (p.Val24Met), gnomAD rs1190770169, REVEL 0.10, CADD 10.10
- E25G (p.Glu25Gly), ExAC rs772025014, TOPMed rs772025014, gnomAD rs772025014, REVEL 0.16, CADD 0.22
- E25K (p.Glu25Lys), gnomAD rs1479063880, REVEL 0.05, CADD 1.46
- Y26F (p.Tyr26Phe), TOPMed rs1247312085, gnomAD rs1247312085, REVEL 0.09, CADD 13.30
- R27* (p.Arg27Ter), Ensembl rs866834987
- R27G (p.Arg27Gly), Ensembl rs866834987, REVEL 0.05, CADD 6.36
- R27T (p.Arg27Thr), gnomAD rs1199221492, REVEL 0.06, CADD 0.01
- A28E (p.Ala28Glu), 1000Genomes rs147605860, ESP rs147605860, ExAC rs147605860, TOPMed rs147605860, REVEL 0.24, CADD 0.04, Likely benign
- A28T (p.Ala28Thr), TOPMed rs1490506292
- A28V (p.Ala28Val), rs147605860, ClinGen CA3532006, cosmic curated COSV57154, ClinVar RCV004212621, REVEL 0.07, CADD 0.01, Likely benign, not specified
- E29D (p.Glu29Asp), TOPMed rs1158869244, REVEL 0.04, CADD 2.34
- V30I (p.Val30Ile), Ensembl rs766347561, REVEL 0.14, CADD 13.60
- G31S (p.Gly31Ser), cosmic curated COSV10885, ExAC rs752806981, TOPMed rs752806981, gnomAD rs752806981, REVEL 0.63, CADD 24.20
- N33S (p.Asn33Ser), Ensembl rs1757261776, REVEL 0.12, CADD 14.70
- Y35I (p.Tyr35Ile), NCI-TCGA Cosmic COSV5715, Variant assessed as somatic; high impact.
- L36M (p.Leu36Met), rs2480412815, ClinGen CA361955705, ClinVar RCV004137210, Uncertain significance, not specified
- F39L (p.Phe39Leu), rs41283181, ClinGen CA3532002, ClinVar RCV004319312, ESP rs41283181, REVEL 0.03, CADD 2.66, Uncertain significance, not specified
- Y40F (p.Tyr40Phe), NCI-TCGA TCGA novel, Variant assessed as somatic; moderate impact.
- T41A (p.Thr41Ala), rs1488560271, NCI-TCGA Cosmic COSV1003, cosmic curated COSV10032, TOPMed rs1488560271, REVEL 0.03, CADD 3.43, Variant assessed as somatic; moderate impact.
- T41I (p.Thr41Ile), ExAC rs751807490, TOPMed rs751807490, gnomAD rs751807490, REVEL 0.23, CADD 9.18
- T41N (p.Thr41Asn), ExAC rs751807490, TOPMed rs751807490, gnomAD rs751807490, REVEL 0.03, CADD 6.88
- T41P (p.Thr41Pro), TOPMed rs1488560271, gnomAD rs1488560271, REVEL 0.07, CADD 15.80
- P42S (p.Pro42Ser), cosmic curated COSV57152, gnomAD rs1757261319, REVEL 0.07, CADD 9.45
- A43G (p.Ala43Gly), Ensembl rs2113696127
- A43P (p.Ala43Pro), rs763316244, ClinGen CA3531998, ClinVar RCV004399269, ExAC rs763316244, REVEL 0.06, CADD 0.00, Uncertain significance, not specified
- A43T (p.Ala43Thr), NCI-TCGA Cosmic COSV5715, cosmic curated COSV57153, Variant assessed as somatic; moderate impact.
- A44S (p.Ala44Ser), ExAC rs765773071, TOPMed rs765773071, gnomAD rs765773071, REVEL 0.02, CADD 0.00
- A44T (p.Ala44Thr), rs765773071, NCI-TCGA Cosmic COSV5715, cosmic curated COSV57152, ExAC rs765773071, REVEL 0.02, CADD 0.00, Variant assessed as somatic; moderate impact.
- P45Q (p.Pro45Gln), NCI-TCGA TCGA novel, TOPMed rs1757260954, gnomAD rs1757260954, REVEL 0.15, CADD 15.80, Variant assessed as somatic; high impact.
- G46E (p.Gly46Glu), cosmic curated COSV57154, gnomAD rs1450374496, REVEL 0.10, CADD 2.95
- G46W (p.Gly46Trp), cosmic curated COSV57154, TOPMed rs1190700485, gnomAD rs1190700485, REVEL 0.05, AlphaMissense 0.17
- N47D (p.Asn47Asp), gnomAD rs1316059430, REVEL 0.11, CADD 0.07
- N47K (p.Asn47Lys), ExAC rs776185551, TOPMed rs776185551, gnomAD rs776185551, REVEL 0.12, CADD 0.37
- V49G (p.Val49Gly), NCI-TCGA Cosmic COSV5715, Variant assessed as somatic; moderate impact.
- V49L (p.Val49Leu), ExAC rs768093433, TOPMed rs768093433, gnomAD rs768093433, REVEL 0.07, CADD 15.40, Uncertain significance
- V49M (p.Val49Met), rs768093433, ClinGen CA361955425, ClinVar RCV003312637, ExAC rs768093433, REVEL 0.07, CADD 21.70, Uncertain significance, not provided
- P50T (p.Pro50Thr), gnomAD rs1257402601, REVEL 0.16, CADD 22.00
- V51A (p.Val51Ala), 1000Genomes rs369697820, ESP rs369697820, ExAC rs369697820, gnomAD rs369697820
- V51I (p.Val51Ile), rs368534648, NCI-TCGA Cosmic COSV5715, cosmic curated COSV57154, ExAC rs368534648, REVEL 0.05, CADD 9.59, Variant assessed as somatic; moderate impact.
- V51L (p.Val51Leu), ExAC rs368534648, TOPMed rs368534648, gnomAD rs368534648
- C52F (p.Cys52Phe), Ensembl rs1561624547, REVEL 0.55, CADD 24.60
- G54C (p.Gly54Cys), gnomAD rs1228657999, REVEL 0.46, CADD 25.20
- G54D (p.Gly54Asp), NCI-TCGA TCGA novel, Ensembl rs1757260327, Variant assessed as somatic; moderate impact.
- G54S (p.Gly54Ser), gnomAD rs1228657999, REVEL 0.44, CADD 24.70
- K55E (p.Lys55Glu), TOPMed rs1445912667, Uncertain significance, not specified
- K55R (p.Lys55Arg), NCI-TCGA TCGA novel, Variant assessed as somatic; moderate impact.
- G56V (p.Gly56Val), cosmic curated COSV57154, ExAC rs745654124, gnomAD rs745654124, REVEL 0.22, AlphaMissense 0.28
- A57S (p.Ala57Ser), ExAC rs778630704, gnomAD rs778630704
- A57T (p.Ala57Thr), ExAC rs778630704, gnomAD rs778630704, REVEL 0.06, CADD 0.05
- C58F (p.Cys58Phe), NCI-TCGA TCGA novel, Variant assessed as somatic; moderate impact.
- C58R (p.Cys58Arg), TOPMed rs201750016, gnomAD rs201750016, REVEL 0.46, CADD 25.30
- P59L (p.Pro59Leu), NCI-TCGA Cosmic COSV5715, cosmic curated COSV57152, Variant assessed as somatic; moderate impact.
- P59S (p.Pro59Ser), NCI-TCGA Cosmic COSV5715, cosmic curated COSV57154, REVEL 0.32, CADD 24.90, Variant assessed as somatic; moderate impact.
- V60A (p.Val60Ala), Ensembl rs1757260017, REVEL 0.07, CADD 7.54
- V60M (p.Val60Met), NCI-TCGA TCGA novel, REVEL 0.13, CADD 0.04, Variant assessed as somatic; moderate impact.
- E62A (p.Glu62Ala), TOPMed rs1410983077
- E62K (p.Glu62Lys), Ensembl rs2113696051
- C63Y (p.Cys63Tyr), gnomAD rs1328023154, REVEL 0.50, CADD 23.60
- G64S (p.Gly64Ser), TOPMed rs1757259829, Uncertain significance, not specified
- N65T (p.Asn65Thr), TOPMed rs1447655980, gnomAD rs1447655980, REVEL 0.10, CADD 0.01
- N65Y (p.Asn65Tyr), TOPMed rs1404949284, gnomAD rs1404949284, REVEL 0.25, CADD 4.42
- V66L (p.Val66Leu), ExAC rs770877887, TOPMed rs770877887, gnomAD rs770877887
- V66M (p.Val66Met), cosmic curated COSV57152, ExAC rs770877887, TOPMed rs770877887, gnomAD rs770877887, REVEL 0.07, CADD 0.07
- V67M (p.Val67Met), ESP rs377032621, ExAC rs377032621, TOPMed rs377032621, gnomAD rs377032621, REVEL 0.07, CADD 8.01
- R69K (p.Arg69Lys), NCI-TCGA Cosmic COSV5715, cosmic curated COSV57151, REVEL 0.06, CADD 0.76, Variant assessed as somatic; moderate impact.
- R69S (p.Arg69Ser), Ensembl rs2113696023
- R69W (p.Arg69Trp), NCI-TCGA Cosmic COSV1003, cosmic curated COSV10032, Variant assessed as somatic; moderate impact.
- T70I (p.Thr70Ile), Ensembl rs1561624502
- D71N (p.Asp71Asn), ExAC rs755070324, gnomAD rs755070324, REVEL 0.12, CADD 9.57, Uncertain significance, not specified
- E72K (p.Glu72Lys), rs747172640, ExAC rs747172640, TOPMed rs747172640, gnomAD rs747172640, REVEL 0.10, CADD 11.80, Variant assessed as somatic; moderate impact.
- R73K (p.Arg73Lys), ExAC rs780255978, TOPMed rs780255978, gnomAD rs780255978, REVEL 0.07, CADD 1.42
- R73T (p.Arg73Thr), ExAC rs780255978, TOPMed rs780255978, gnomAD rs780255978
- D74E (p.Asp74Glu), ESP rs372130478, ExAC rs372130478, TOPMed rs372130478, gnomAD rs372130478, REVEL 0.00, CADD 0.14, Uncertain significance, not specified
- D74G (p.Asp74Gly), NCI-TCGA Cosmic COSV1003, cosmic curated COSV10032, Variant assessed as somatic; moderate impact.
- D74Y (p.Asp74Tyr), NCI-TCGA Cosmic COSV5715, cosmic curated COSV57152, Variant assessed as somatic; moderate impact.
- V75L (p.Val75Leu), NCI-TCGA Cosmic COSV5715, cosmic curated COSV57153, Variant assessed as somatic; moderate impact.
- V75M (p.Val75Met), Ensembl rs1561624488, REVEL 0.18, CADD 10.80
- Y77C (p.Tyr77Cys), gnomAD rs1757258438, REVEL 0.33, CADD 19.90
- W78R (p.Trp78Arg), Ensembl rs2113695989, REVEL 0.10, CADD 9.71
- T79S (p.Thr79Ser), ExAC rs765572672, gnomAD rs765572672, REVEL 0.04, CADD 0.13
- S80Y (p.Ser80Tyr), NCI-TCGA TCGA novel, Variant assessed as somatic; moderate impact.
- R81G (p.Arg81Gly), TOPMed rs1205336670, gnomAD rs1205336670, REVEL 0.20, CADD 16.20
- Y82C (p.Tyr82Cys), rs184868814, ClinGen CA3531978, cosmic curated COSV57153, ClinVar RCV000768411, REVEL 0.67, CADD 24.80, Conflicting interpretations, Subcutaneous panniculitis T-cell lymphoma (SPTCL); Subcutaneous panniculitis-lik
- W83G (p.Trp83Gly), ExAC rs754336008, TOPMed rs754336008, gnomAD rs754336008, REVEL 0.08, CADD 12.40
- W83R (p.Trp83Arg), ExAC rs754336008, TOPMed rs754336008, gnomAD rs754336008, REVEL 0.05, CADD 8.25
- N85D (p.Asn85Asp), Ensembl rs1757258079
- N85I (p.Asn85Ile), ESP rs376605513, ExAC rs376605513, TOPMed rs376605513, gnomAD rs376605513, REVEL 0.06, CADD 14.00
- N85K (p.Asn85Lys), 1000Genomes rs552358033, ExAC rs552358033, TOPMed rs552358033, gnomAD rs552358033, REVEL 0.10, CADD 0.09
- N85S (p.Asn85Ser), ESP rs376605513, ExAC rs376605513, TOPMed rs376605513, gnomAD rs376605513, REVEL 0.08, CADD 10.60, Uncertain significance, not specified
- G86R (p.Gly86Arg), TOPMed rs1757257923, gnomAD rs1757257923, REVEL 0.23, CADD 12.90
- D87E (p.Asp87Glu), NCI-TCGA Cosmic COSV5715, cosmic curated COSV57153, Variant assessed as somatic; moderate impact.
- D87Y (p.Asp87Tyr), TOPMed rs1757257889, REVEL 0.15, CADD 0.01
- F88I (p.Phe88Ile), gnomAD rs1287543382, REVEL 0.06, CADD 0.16
- R89C (p.Arg89Cys), rs372946929, NCI-TCGA Cosmic COSV5715, cosmic curated COSV57154, 1000Genomes rs372946929, REVEL 0.12, CADD 14.90, Variant assessed as somatic; moderate impact.
- R89G (p.Arg89Gly), 1000Genomes rs372946929, ExAC rs372946929, TOPMed rs372946929, gnomAD rs372946929, REVEL 0.03, CADD 5.75
- R89H (p.Arg89His), rs759158630, NCI-TCGA Cosmic COSV5715, cosmic curated COSV57152, ExAC rs759158630, REVEL 0.04, CADD 0.09, Variant assessed as somatic; moderate impact.
- R89L (p.Arg89Leu), ExAC rs759158630, TOPMed rs759158630, gnomAD rs759158630
- G91E (p.Gly91Glu), Ensembl rs763321879, REVEL 0.37, CADD 23.40
- D92E (p.Asp92Glu), NCI-TCGA Cosmic COSV5715, Variant assessed as somatic; high impact.
- D92G (p.Asp92Gly), TOPMed rs1757257597, REVEL 0.20, CADD 23.60
- D92H (p.Asp92His), 1000Genomes rs181855375, ExAC rs181855375, TOPMed rs181855375, gnomAD rs181855375
- D92N (p.Asp92Asn), 1000Genomes rs181855375, ExAC rs181855375, TOPMed rs181855375, gnomAD rs181855375, REVEL 0.06, CADD 6.79, Likely benign, not specified
- T96I (p.Thr96Ile), ExAC rs749196778, gnomAD rs749196778, REVEL 0.20, CADD 19.10
- T96N (p.Thr96Asn), ExAC rs749196778, gnomAD rs749196778, REVEL 0.42, CADD 22.60
- I97M (p.Ile97Met), rs35960726, ClinGen CA3531967, ClinVar RCV000768412, ClinVar RCV001310880, REVEL 0.30, CADD 18.60, Conflicting interpretations, Subcutaneous panniculitis-like T-cell lymphoma; not provided
- I97T (p.Ile97Thr), cosmic curated COSV57153, TOPMed rs1158946084, gnomAD rs1158946084, REVEL 0.54, CADD 24.20, Uncertain significance, not specified
- E98D (p.Glu98Asp), gnomAD rs1757257160, NCI-TCGA Cosmic COSV5715, cosmic curated COSV57152, REVEL 0.05, CADD 5.99, Variant assessed as somatic; moderate impact.
- E98G (p.Glu98Gly), ExAC rs768652236, gnomAD rs768652236, REVEL 0.05, CADD 7.35
- N99S (p.Asn99Ser), gnomAD rs1183555178, REVEL 0.10, CADD 16.50
- V100A (p.Val100Ala), Ensembl rs1757257090
- T101I (p.Thr101Ile), rs147827860, ClinGen CA3531965, cosmic curated COSV57153, ClinVar RCV000768413, REVEL 0.28, CADD 22.60, Benign, not provided
- T101P (p.Thr101Pro), TOPMed rs1581763917, REVEL 0.36, CADD 22.40, Uncertain significance, in SPTCL
- T101S (p.Thr101Ser), TOPMed rs1581763917, Uncertain significance, not specified
- L102V (p.Leu102Val), Ensembl rs1757256885, REVEL 0.11, CADD 0.02
- A103V (p.Ala103Val), TOPMed rs971874704, REVEL 0.10, CADD 1.19
- D104G (p.Asp104Gly), gnomAD rs1478141906, REVEL 0.82, CADD 24.70
- S105C (p.Ser105Cys), ESP rs371263443, ExAC rs371263443, TOPMed rs371263443, gnomAD rs371263443
- S105G (p.Ser105Gly), ESP rs371263443, ExAC rs371263443, TOPMed rs371263443, gnomAD rs371263443, REVEL 0.10, CADD 5.67
- S105I (p.Ser105Ile), NCI-TCGA Cosmic COSV1003, cosmic curated COSV10032, Variant assessed as somatic; moderate impact.
- I107F (p.Ile107Phe), rs190484372, ClinGen CA3531960, ClinVar RCV003941489, ClinVar RCV005407288, REVEL 0.07, CADD 16.50, Likely benign, not specified
- I107T (p.Ile107Thr), ExAC rs754313394, TOPMed rs754313394, gnomAD rs754313394, REVEL 0.04, CADD 7.08
- C109R (p.Cys109Arg), Ensembl rs1561624420, REVEL 0.56, CADD 25.20
- C110F (p.Cys110Phe), NCI-TCGA Cosmic COSV1044, TOPMed rs1757256363, Variant assessed as somatic; moderate impact.
- C110Y (p.Cys110Tyr), cosmic curated COSV10441, TOPMed rs1757256363
- R111Q (p.Arg111Gln), rs367701067, ClinGen CA3531956, cosmic curated COSV10032, ClinVar RCV001354547, REVEL 0.41, CADD 25.30, Uncertain significance, Subcutaneous panniculitis-like T-cell lymphoma
- R111W (p.Arg111Trp), cosmic curated COSV10032, ESP rs145478313, ExAC rs145478313, TOPMed rs145478313, REVEL 0.56, CADD 24.80
- P115A (p.Pro115Ala), NCI-TCGA Cosmic COSV5715, cosmic curated COSV57154, Variant assessed as somatic; moderate impact.
- P115R (p.Pro115Arg), TOPMed rs1271847175, gnomAD rs1271847175, REVEL 0.25, CADD 23.10
- G116D (p.Gly116Asp), ExAC rs759186529, gnomAD rs759186529, REVEL 0.40, CADD 23.80
- I117L (p.Ile117Leu), rs773895230, ClinGen CA361954163, ClinVar RCV004120945, ClinVar RCV004790420, AlphaMissense 0.13, MetaLR 0.02, Conflicting interpretations, not provided; not specified
- I117M (p.Ile117Met), TOPMed rs1757256066, REVEL 0.10, CADD 4.02
- I117V (p.Ile117Val), ExAC rs773895230, gnomAD rs773895230, REVEL 0.03, AlphaMissense 0.13, Likely benign
- M118T (p.Met118Thr), gnomAD rs1438841374
- N119T (p.Asn119Thr), NCI-TCGA Cosmic COSV1003, Variant assessed as somatic; moderate impact.
- N119Y (p.Asn119Tyr), NCI-TCGA Cosmic COSV5715, cosmic curated COSV57154, Variant assessed as somatic; moderate impact.
- D120N (p.Asp120Asn), 1000Genomes rs201054625, ESP rs201054625, ExAC rs201054625, TOPMed rs201054625, REVEL 0.34, CADD 24.40
- E121K (p.Glu121Lys), cosmic curated COSV10460, Ensembl rs1757255896
- F123C (p.Phe123Cys), cosmic curated COSV57153, ESP rs372728833, ExAC rs372728833, gnomAD rs372728833, REVEL 0.22, CADD 8.83
- F123V (p.Phe123Val), gnomAD rs1455925680, REVEL 0.15, CADD 0.05
- N124S (p.Asn124Ser), ExAC rs773053705, TOPMed rs773053705, gnomAD rs773053705, REVEL 0.16, CADD 5.34
- L125P (p.Leu125Pro), NCI-TCGA Cosmic COSV1003, cosmic curated COSV10032, Variant assessed as somatic; moderate impact.
- K126N (p.Lys126Asn), TOPMed rs1757255683
- L127F (p.Leu127Phe), NCI-TCGA Cosmic COSV5715, cosmic curated COSV57155, Variant assessed as somatic; moderate impact.
- V128I (p.Val128Ile), TOPMed rs1757255621
- I129V (p.Ile129Val), rs2480412154, ClinGen CA361953835, ClinVar RCV004103120, REVEL 0.04, CADD 14.80, Uncertain significance, not specified
- K130E (p.Lys130Glu), TOPMed rs1462397462, REVEL 0.03, CADD 19.20
- K130N (p.Lys130Asn), TOPMed rs1206400189, gnomAD rs1206400189, REVEL 0.10, CADD 24.00
- K130R (p.Lys130Arg), ExAC rs772172803, gnomAD rs772172803, REVEL 0.06, CADD 1.56
- A132T (p.Ala132Thr), cosmic curated COSV10966, gnomAD rs1246966884, REVEL 0.03, CADD 24.30
- A132V (p.Ala132Val), TOPMed rs1395748743, gnomAD rs1395748743, REVEL 0.05, CADD 22.90
- V134A (p.Val134Ala), gnomAD rs773216921, REVEL 0.07, CADD 23.40
- T135I (p.Thr135Ile), TOPMed rs1561623689, REVEL 0.02, CADD 16.40, Uncertain significance
- T135P (p.Thr135Pro), Ensembl rs1581762871
- T135S (p.Thr135Ser), TOPMed rs1561623689, Uncertain significance, not provided
Public HAVCR2 analysis runs
- HAVCR2 analysis run — HAVCR2 (596 variants) — completed 2026-08-21